Literature DB >> 18239388

Outcome of renal insufficiency patients undergoing coronary artery bypass graft surgery.

Amala P Chirumamilla1, Michael F Wilson, Gregory E Wilding, Rameela Chandrasekhar, Hashmat Ashraf.   

Abstract

Renal insufficiency (RI) is a prognostic marker in patients with cardiovascular disease. In this study, the latest standard of glomerular filtration rate (GFR) calculation, that is the modification of diet in renal disease (MDRD) study equation, is used to measure the difference in the outcome of coronary artery bypass graft (CABG) surgery in various GFR groups. Between 2000 and 2005, 1,055 patients underwent CABG surgery and were categorized into 5 groups according to the National Kidney Foundation guidelines: stage 1 = normal renal function; stage 2 = mild RI; stage 3 = moderate RI; stage 4 = severe RI; stage 5 = end-stage renal failure (excluded). Precautions were taken in RI patients to avoid perioperative hypotension, fluid overload and limited cardioplegia; cardiopulmonary bypass time was kept at a minimum by performing an essential number of grafts only. Thirty-day mortality occurred in 5 of 1,052 patients (0.48%) with no statistical difference in stages 1-4. There was increase in bleed requiring reoperation and total complications from stages 1 to 4, but it was not statistically significant. Preoperative renal dysfunction in CABG surgery patients is an important predictor of outcome. Patients undergoing CABG surgery can have acceptable results without significant increase in complications and mortality provided that risk factors are minimized perioperatively. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18239388     DOI: 10.1159/000113423

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  7 in total

1.  Incremental prognostic value of kidney function decline over coronary artery disease for cardiovascular event prediction after coronary computed tomography.

Authors:  Marcio S Bittencourt; Edward A Hulten; Brian Ghoshhajra; Suhny Abbara; Venkatesh L Murthy; Sanjay Divakaran; Khurram Nasir; Luis Henrique W Gowdak; Leonardo V Riella; Marco Chiumiento; Udo Hoffmann; Marcelo F Di Carli; Ron Blankstein
Journal:  Kidney Int       Date:  2015-01-28       Impact factor: 10.612

2.  Leukocyte-Aprotinin Atrial Fibrillation Study (LAFFS): Impact of Aprotinin and Leukofiltration on Atrial Fibrillation, Renal Insufficiency and Encephalopathy Post-Cardiopulmonary Bypass.

Authors:  Albert H O-Yurvati; Steven Rodriguez; Glen Bell; Damon Kennedy; Robert T Mallet
Journal:  J Atr Fibrillation       Date:  2008-12-01

3.  Different treatment options in chronic coronary artery disease: when is it the time for medical treatment, percutaneous coronary intervention or aortocoronary bypass surgery?

Authors:  Martin Russ; Karl Werdan; Jochen Cremer; Arno Krian; Thomas Meinertz; Hans-Reinhard Zerkowski
Journal:  Dtsch Arztebl Int       Date:  2009-04-10       Impact factor: 5.594

4.  Chronic kidney disease in patients with significant left main coronary artery disease qualified for coronary artery bypass graft operation.

Authors:  Malgorzata Zalewska-Adamiec; Hanna Bachorzewska-Gajewska; Jolanta Malyszko; Jacek S Malyszko; Pawel Kralisz; Anna Tomaszuk-Kazberuk; Tomasz Hirnle; Slawomir Dobrzycki
Journal:  Arch Med Sci       Date:  2015-04-23       Impact factor: 3.318

Review 5.  Coronary revascularization in the elderly with stable angina.

Authors:  Kirill Lenarovich Kozlov; Aleksandr Andreevich Bogachev
Journal:  J Geriatr Cardiol       Date:  2015-09       Impact factor: 3.327

6.  Blood and urinary cytokine balance and renal outcomes at cardiac surgery.

Authors:  William T McBride; Mary Jo Kurth; Anna Domanska; Joanne Watt; Gavin McLean; Jijin Joseph; John V Lamont; Peter Fitzgerald; Mark W Ruddock
Journal:  BMC Nephrol       Date:  2021-12-08       Impact factor: 2.388

7.  Outcomes of off-pump coronary artery bypass grafting in non-dialysis-dependent patients with stage 2 and stage 3 chronic kidney disease.

Authors:  Sudipto Bhattacharya
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2021-03-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.